Skip to Content
Merck
  • Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9.

Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9.

Stem cell research (2016-11-24)
Anne M Bara, Angelica Messana, Amanda Herring, Dane Z Hazelbaker, Kevin Eggan, Lindy E Barrett
PMID27879221
ABSTRACT

Here, we generated a monoallelic mutation in the TLE3 (Transducin Like Enhancer of Split 3) gene using CRISPR-Cas9 editing in the human embryonic stem cell (hESC) line WA01. The heterozygous knockout cell line, TLE3-447-D08-A01, displays partial loss of TLE3 protein expression while maintaining pluripotency, differentiation potential and genomic integrity.

MATERIALS
Product Number
Brand
Product Description
A2547
Sigma-Aldrich
Monoclonal Anti-Actin, α-Smooth Muscle, clone 1A4, ascites fluid
A8452
Sigma-Aldrich
Monoclonal Anti-α-Fetoprotein (AFP) antibody produced in mouse, ascites fluid, clone C3